DUBLIN--(BUSINESS WIRE)--The "Global NGS Informatics and Clinical Genomics Market: Focus on Product Types (LIMS, Data Analysis and Interpretation Tools, and Storage and Computing Solutions), End Users, and Regional Analysis for 21 Countries: Analysis and Forecast (2018-2028)" report has been added to ResearchAndMarkets.com's offering.
North America is the leading region in the NGS informatics and clinical genomics market accounting for approximately 45.45% and has an estimated value of $380.0 million (as of 2017).
The U.S. is the clear regional leader in the North America market with an estimated value of $361.0 million. The major reason for the growth in this region is the rapidly increasing number of genomics projects funded by government which will be providing millions of dollars for the next couple of years to have thousands of patient genomes sequenced.
The dynamics of the overall market depicts that the NGS informatics and clinical genomics space offers huge profitability to investors willing to enter the market. The year 2017 witnessed numerous series of fundings from investors to companies working on data management, analysis, and interpretation of NGS data.
For example, companies such as Genoox have been potentially funded ($6 million investment) by Inimiti Capital and Glilot Capital Partners (two Israeli venture capital firms) for developing a platform for interpretation of NGS data through a search engine.
Key Topics Covered:
Executive Summary
1 Market Overview
2 Market Dynamics
3 Competitive Insights
4 Industry Attractiveness and Insights
5 Key Industry Insights
6 Global NGS Informatics and Clinical Genomics Market: Analysis and Forecast
7 Global NGS Informatics and Clinical Genomics Market (by Technology)
8 Global NGS Informatics and Clinical Genomics Market (by Product Type)
9 Global NGS Informatics and Clinical Genomics Market (by End User)
10 Global NGS Informatics and Clinical Genomics Market (by Region)
11 Company Profiles
- 2bPrecise, LLC
- Amazon Web Services, Inc.
- Beijing Genomic Institute (BGI)
- Cota, Inc.
- CureMatch, Inc.
- DNASTAR
- DNAnexus, Inc.
- DrChrono Inc.
- Eagle Genomics
- Edico Genome
- Epic Systems Corporation
- F. Hoffmann-La Roche AG
- Fabric Genomics, Inc. (Formerly Omicia, Inc.)
- Flatiron Health, Inc. (Subsidiary of Roche Group Company)
- Genalice
- GenomOncology, LLC
- Genomatix AG
- IBM Corporation
- Illumina, Inc.
- Interpreta, Inc.
- Koninklijke Philips N.V.
- LunaDNA Inc.
- N-of-One, Inc.
- NantHealth, Inc.
- Navican Genomics, Inc.
- Orion Health Group Limited
- Partek Incorporated
- QIAGEN N.V.
- SAP SE
- SOPHiA GENETICS SA
- Seven Bridges Genomics Inc.
- Syapse, Inc.
- Tempus Labs, Inc.
- Verily Life Sciences LLC
- WuxiNextCode
For more information about this report visit https://www.researchandmarkets.com/research/sn5jjk/global_ngs?w=4
